B. Braun SE, a leading global healthcare company headquartered in Germany, has been at the forefront of medical technology since its founding in 1839. With a strong presence in Europe, Asia, and the Americas, B. Braun operates within the medical devices and pharmaceutical sectors, focusing on innovative solutions for hospitals and outpatient care. The company is renowned for its extensive range of products, including infusion therapy systems, surgical instruments, and anaesthesia equipment, all designed to enhance patient safety and improve clinical outcomes. B. Braun's commitment to quality and sustainability has solidified its position as a trusted partner in the healthcare industry, earning numerous accolades for its contributions to medical advancements. With a rich history and a forward-thinking approach, B. Braun SE continues to shape the future of healthcare.
How does B. Braun Se's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
B. Braun Se's score of 4 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, B. Braun SE reported total carbon emissions of approximately 568,000,000 kg CO2e, a decrease from about 612,300,000 kg CO2e in 2022 and 653,400,000 kg CO2e in 2021. These figures represent Scope 1 and 2 emissions, indicating the company's direct and indirect emissions from energy use. B. Braun has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 CO2 emissions by 50% by 2030, using 2021 as the baseline year. This target reflects the company's proactive approach to mitigating its environmental impact and aligns with industry standards for climate action. The emissions data is cascaded from B. Braun SE, which is committed to sustainability and reducing its carbon footprint across its global operations. The company is currently on track to meet its near-term reduction goals, demonstrating a strong commitment to environmental responsibility.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - | 
| Scope 2 | - | - | - | 
| Scope 3 | - | - | - | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
B. Braun Se has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
